drugset / Trial / NCT00762372
Japan Phase 2/3 Clinical Study With BLM-240 (Desflurane)
RandomizedParallel-groupOpen-labelTreatment
Summary
The purposes of this study are to evaluate the efficacy and safety of desflurane (BLM-240) as an anesthetic agent and to demonstrate the non-inferiority of desflurane to sevoflurane in term of awakening/recovery from anesthesia.
Timeline
- Start
- 2008-02
- Primary completion
- 2008-08
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desflurane | Other / unclassified | — | Inhaled |
| Subject | Nitrous Oxide | Other / unclassified | — | Inhaled |
| Comparator | Sevoflurane | Other / unclassified | — | Inhaled |
Indications
No indication recorded.